Cysteamine Bitartrate

酒石酸巯乙胺

Report date: 2022/05/12 17:25:09
NME

Base Information

Drug NameCysteamine Bitartrate
Drug Alias NameMercaptamine BitartrateNicystagonProcysbiLynovexCystagon +[12] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutathione synthase stimulants
TargetsGlutathione synthase
Therapy Area/IndicationsMitochondrial DiseasesCystinosisCystic Fibrosis +[4] 
Global Approved IndicationsCystinosis
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1994/08/15
Country/TerritoryBelgiumCanadaUnited States +[10] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesMylan Nv
China Registration ClassN/A

Develop Information

Active CompaniesHorizon Therapeutics Ireland DacRecordati Rare Diseases IncMylan Nv +[6] 
Inactive CompaniesAmgen IncNational Eye Institute (Nei)University Of Aberdeen +[4] 
Active IndicationsCystinosis
Inactive IndicationsMitochondrial DiseasesCystic FibrosisMetabolic Dysfunction-Associated Steatotic Liver Disease

Other Information

ATC CodeA16AA04S01XA21
Related LinksWikipediaDrugBankKEGG